Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 10th International Conference on Ophthalmology and Optometry Beijing, China.

Day 2 :

Keynote Forum

Fuxiang Zhang

Medical Director

Keynote: Modern Refractive Cataract Surgery-Foundation and Options

Time : 09:30

OMICS International Ophthalmology Conference 2017  International Conference Keynote Speaker Fuxiang Zhang photo

Dr. Fuxiang Zhang, MD, MA, completed his first ophthalmology residency training in China. He came to the USA in 1989 and completed his second ophthalmology residency training at Kellogg Eye Center, University of Michigan from 1994-1997. He has been a senior staff member at the Department of Ophthalmology, Henry Ford Health System since 1999. Dr. Zhang’s practice has focused on refractive cataract surgery and IOL monovision for the last 20 years. He has been frequently invited as an honorable or keynote speaker, and has been invited to be a guest editorial board member by numerous ophthalmology journals. He has been jointly invited by ASCRS and AAO to be in charge of the Breakfast with the Expert round table seminar at the American Academy of Ophthalmology since 2014. His clinical research and numerous publications in prestigious journals have been focused on refractive cataract surgery and IOL monovision.


Cataract surgery is no longer simple vision rehabilitation any more. More and more patients require or even demand postoperative spectacle independence. This presentation will explain the spectrum of modern refractive cataract surgery, including the foundation as well as current popular premium IOLs, advantages and disadvantages of each modality.

Keynote Forum

G. Y. Mu


Keynote: Progress of corneal collagen crosslinking

Time : 10:05

OMICS International Ophthalmology Conference 2017  International Conference Keynote Speaker G. Y. Mu photo

Guo-Ying Mu majors in the basic research and clinical treatment for ametropia, cataract and corneal diseases, especially for the treatment of karatoconus and infectious corneal diseases and has more than 20 related SCI papers have been published in international core journals. He has also participated in the editing of 6 monographs.


This review overviews the theoretical basis of corneal collagen crosslinking (CXL) and aims to highlight the advances in this procedure to optimize the efficacy of its clinical applications. It consists of the development history of CXL, physical-chemical changes after CXL, clinical applications of CXL, scleral crosslinking and key elements of CXL. CXL was first introduced in the 1990s and has been adopted as a primary treatment for corneal ectatic disorders such as keratoconus worldwide. By using the combination of Riboflavin and ultraviolet-A (UVA), this method is aimed to increase the corneal biomechanical strength and reduce the requirement for corneal transplantation. Over the past decades, many scientific studies have demonstrated the safety and efficacy of this new minimally-invasive method which has been applied to treat infectious keratitis and bullous keratopathy other than keratoconus. However, more and more laboratory and clinical researches were performed to optimize the effect of this procedure by modifications to the standard treatment protocol, such as methods to remove corneal epithelium, the differences between the CXL procedure with or without epithelium and the way to treat thin corneas less than 400 um. Furthermore, the scleral CXL remains a concern in the future.

Keynote Forum

Bhartendu Shukla

Director, India


Time : 10:55

OMICS International Ophthalmology Conference 2017  International Conference Keynote Speaker Bhartendu Shukla photo

Prof.B.Shukla  has teaching experience at Medical Cololege,Gwalior for 25 years. Susequently he was Director, Regional Institute of Ophthalmology, Bhopoal for 9 years and now as Director of Research at R.J.N. for 9 years. He has been President All India OphthalmologicalSociety& President, Ocular Trauma Society of India. He received Dr. Siva Reddy International Award and important natioinal awards including Dr.Hari Mohan Award, Air Marshal Boparai Award, Community Ophthalmology Award, Dr.A.K.N. Sinha Award and Dr. Mohan Lal Award. He also receiuved Life Time Achievements Award of All India Ophthalmological Society. Dr.Shukla has over 50 publications in various national and international journals.


In physical sciences like physics, chemistry and engineering, it is relatively easy to quantify change. However in medical science it is not always easy and at times we have to make a compromise. An effort has been made to quantify ocular trauma (eye injuries) on the basis of loss of structure and loss of function. The loss of structure is graded in percentage on the basis a formula and the loss of function is mainly calculated from loss of vision in percentage. Loss of structural and functional loss gives total loss. Both should be recorded on a graph paper at weekly interval for moderate injuries and at monthly interval for severe injuries. By joining the upper ends of structural and functional loss an area is formed which is called traumagram. Sq. cm. within this area are counted .Each represents 1 trauma unit. Many types of traumagrams can be expected.